Solaris Endovascular today announced its formation to develop solutions for dialysis access and treating peripheral artery ...

The CLEAR SYNERGY (OASIS 9) study, called "the largest trial ever ... More than 95% of patients were implanted with a drug-eluting stent. At month 3, C-reactive protein levels were significantly lower ...

A “bioadaptive” stent might circumvent the slow accumulation of target lesion failure that has been a consistent weakness of ...